Kingdon Capital Management, L.L.C. Infla Rx N.V. Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.78 - $1.9 $57,610 - $140,334	-73,860 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.83 - $4.48 $459,586 - $1.13 Million	-251,140 Reduced 77.27%	73,860 $135,000
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $176,250 - $418,500	-75,000 Reduced 18.75%	325,000 $1.55 Million
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $1.45 Million - $2.54 Million	400,000 New	400,000 $1.56 Million
Q2 2019 Aug 14, 2019	SELL	$3.06 - $51.61 $536,766 - $9.05 Million	-175,414 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$31.16 - $48.62 $5.47 Million - $8.53 Million	175,414 New	175,414 $6.63 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $111M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.